This is a preview of subscription content, log in via an institution to check access.
Reference
Ganz PA, et al. Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial. Lancet : 10 Dec 2015. Available from: URL: http://dx.doi.org/10.1016/S0140-6736(15)01169-1
Rights and permissions
About this article
Cite this article
Anastrozole or tamoxifen: similar QOL, differing side effects. PharmacoEcon Outcomes News 743, 14 (2015). https://doi.org/10.1007/s40274-015-2679-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-2679-4